Advertisement

Topics

Companies Related to "Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose." [Most Relevant Company Matches] RSS

10:11 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose." found in our extensive corporate database of over 50,000 company records.

Showing "Immunogenicity Safety Study Vaccine Against Meningitis Infants Months" Companies 1–25 of 2,300+

Extremely Relevant

Meningitis Angels

Meningitis Angels is a national nonprofit organization founded in memory of Ryan Wayne Milley, the only child of Bob and Frankie Milley. Ryan's life was taken at age 18, as a result of meningococcal meningitis/meningococcemia. Meningitis Angels is dedicated to the support of victims, of bacterial meningitis and their families. While helping families cope w...


Meningitis Trust

The Meningitis Trust started in 1986 and, since then, has supported people as they face life after meningitis. It provides the widest range of free services and community-based support for people affected by meningitis across the UK, and raises awareness of the disease and funds research into its long-term impact.

Relevant

Smithers Avanza

Smithers Avanza is a contract research organization known for superior quality, on-time delivery, flexibility, and responsiveness. Our laboratories support the pharmaceutical and chemical industries. At our GLP, cGMP, and AAALAC accredited facilities, our Development Services group offers general toxicology, safety pharmacology, vaccine safety testi...


National Meningitis Association, Inc

The National Meningitis Association, Inc. (NMA) is a national non-profit public charity established in February, 2001. The primary goal of NMA is to increase protection from meningitis and meningococcal disease. The founding directors are Candie Benn from California, Lynn Bozof from Georgia, Mike Kepferle from Maryland, Nancy Springer from New York, and Carolyn Waghorne from Texas. Each of the dir...

Vaxin Inc.

Vaxin Inc. is a clinical stage biotechnology company, founded in December 1997 with facilities in Rockville, MD and Birmingham, AL, developing next generation vaccines to address significant public health and biodefense needs. Vaxin is focused on vaccines designed to protect people against influenza and anthrax infection using proprietary, patented technol...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

VaxInnate Corporation

VaxInnate is a privately-held biotechnology company in Cranbury, NJ that is pioneering breakthrough technology for use in developing novel and proprietary vaccines. VaxInnate’s proprietary technology -- based upon a combination of toll-like receptor-mediated (TLR) immune enhancement and recombinant bacterial production of vaccine antigen -- conveys si...

Shoo the Flu

The flu, also called influenza, is a contagious disease that spreads by coughing, sneezing and close contact. Flu symptoms include fever/chills, sore throat, muscle aches, fatigue, cough and headache. The flu is preventable. The flu vaccine is the most effective way to reduce the chances that people will get the flu and spread it to others. The Centers for...

Geovax Labs

GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining r...

Coalition for Vaccine Safety

Vaccine Safety Conference

National Meningitis Association

TEXCELL

TEXCELL, a spin-off company of the Pasteur Institute, is based in Evry Genopole in more than 16,000 sq. ft of offices and BSL2/BSL3 laboratory facilities. TEXCELL offers GLP/GMP compliant services for viral safety, mycoplasma testing, and bioanalysis (TK/PK, immunogenicity, biomarkers, potency).

Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta's proprietary Synthetic Vaccine Particle (SVP™) platform creates a new paradigm in vaccine developm...

Nabi Biopharmaceuticals

NABI Biopharmaceuticals are a biopharmaceutical company focused on the development of products that address unmet medical needs in the areas of nicotine addiction and infectious disease. We leverage our experience and knowledge in powering the human immune system to target serious medical conditions in these areas. Our lead products in development are NicVAX® [ Nicotine Conjugate Vaccine ], an in...

Biological Mimetics, Inc.,

Biological Mimetics, Inc. (“BMI”) was formed to commercialize innovative pharmaceutical products that will improve the quality of life and overall state of public health by combating resistant and emerging diseases in human and veterinary medicine. Our mission philosophy is to remain a creative and innovative biotechnology firm dedicated to improving the quality of life and overall state of pu...

Sabin Vaccine Institute

Sabin Vaccine Institute is a 501(c)(3) non-profit organization dedicated to reducing human suffering from infectious and neglected diseases. Through its efforts in vaccine research, development and advocacy, Sabin works to provide greater access to vaccines and essential medicines for millions mired in pain, poverty and despair. Founded in 1993 in honor of Dr. Albert B. Sabin, discoverer of the or...

Inviragen, Inc. and PharmaJet, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease and Japanese encephalitis, both of which affect millions of children in Asia. Vaccines in preclin...

Hawaii Biotech, Inc.

Hawaii Biotech, Inc. is a privately held biopharmaceutical company focused on vaccine research and development. The company is targeting first world vaccines with potentially large markets and attractive margins: a West Nile vaccine targeting the U.S. and Canada; and a dengue fever vaccine for travelers from first world countries to dengue endemic areas. The Company’s vaccine technology was feat...

Genetic Immunity, LLC

Genetic Immunity is a biopharmaceutical company focused on therapeutic vaccine development and commercialization. The lead product, DermaVir vaccine patch, is under clinical evaluation in Hungary and in the USA for the treatment for HIV/AIDS, where resistance, toxicity, adherence and cost limit the use of drugs. The Company’s vaccine composition mimics the successful induction of antiviral immun...

Polynoma, Inc.

Polynoma, Inc. is an oncology-focused biotechnology company based in San Diego, the United States of America. Polynoma’s lead product candidate is the therapeutic vaccine POL 103A for the treatment of melanoma. The Phase 3 trial of POL 103A was initiated based on two randomized, controlled Phase 2 trials that showed statistically significant efficacy ...

World of Health Biotech Co.Ltd

Anti HBV Specific Active Immunotherapy (Anti HBV Therapeutic Vaccine) using recombinant hepatitis B vaccine (standard HBV vaccine) as an immunogenic specific antigen and several cytokines as an immune adjuvant is a new antiviral approach for chronic HBV infection. The first and most critical setp in the design of an anti HBV therapeutic vaccine is the selection of the specific antigens that will b...

Biotech Synergy

Biotech Synergy has secured in San Diego the necessary competences to bring this promising multi epitope cancer vaccine to latest stage development. Contrary to Dendreon individualized vaccine, EP-2101 is made of 10 peptides and is an off the shelf readily available vaccine for the HLA-A2 population, which represents 45% of the global NSCLC patients (100,0...

HALO Innovations

Based in Minneapolis, MN, HALO Innovations has a singular mission: to help babies sleep safely. Founded in 1994 by William Schmid, who began researching sleeping environments after he lost an infant daughter to SIDS three years earlier, HALO is dedicated to developing products that set new standards for the safety and improved health of sleeping infants an...

Variation Biotechnologies, Inc.

VBI is an emerging leader in the innovative formulation, delivery and development of vaccines. The Company’s powerful, proprietary technology platforms enable thermostable IM and thermostable oral vaccine delivery, creating improved dose equivalent and the potential for dose sparing and adjuvanted vaccines, extending vaccine reach and coverage in established...


More From BioPortfolio on "Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose."

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks